Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Starpharma Holdings Limited ( (AU:SPL) ) has issued an announcement.
Starpharma Holdings Limited announced that its 2025 Annual General Meeting will be held on November 14, 2025, in Melbourne. The announcement highlights the company’s ongoing commitment to transparency and stakeholder engagement, with the Chair’s address and CEO’s presentation to be released to the market prior to the meeting. This meeting is an opportunity for the company to discuss its strategic direction and operational updates, potentially impacting its market positioning and stakeholder relations.
More about Starpharma Holdings Limited
Starpharma Holdings Limited is an innovative biotechnology company specializing in dendrimer technology, which it has been advancing for over two decades. The company focuses on improving health outcomes for patients with significant illnesses, such as cancer, through its unique dendrimer technology. Starpharma’s product portfolio includes clinical-stage DEP® assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over-the-counter products.
Average Trading Volume: 331,633
Technical Sentiment Signal: Hold
Current Market Cap: A$52.28M
See more insights into SPL stock on TipRanks’ Stock Analysis page.